Innovative muscle patches derived from stem cells demonstrate efficacy in heart repair, improving function in primates and a ...

People diagnosed with congenital heart disease — a heart defect that is present at birth — are more likely to survive thanks ...

Patients with EGFR-mutated non-small cell lung cancer treated with osimertinib experienced more cancer therapy-related ...

St. Joseph's Hospital was identified as one of the nation's 50 Top Cardiovascular Hospitals®, according to an independent ...

Since heart attacks can happen unexpectedly, it helps to be ready: Keep emergency numbers saved on your phone and easily accessible. Learn the symptoms so you can recognize them early. Talk to your ...

For Heart Health Month, Amy Ahnert, MD, discussed the link between cardiovascular disease and breast cancer.

Premier, Inc. announced the nation’s 50 Top Cardiovascular Hospitals® with the full list of recognized hospitals published in ...

The Medicare data contradict results from the TCW randomized trial but better represent real-world practice, say authors.

Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...

Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

After combing through 4,000 existing medications, an artificial intelligence tool helped uncover one that saved the life of a patient with idiopathic multicentric Castleman's disease (iMCD).